Equity
€1,000 from €428,981 in 2024
Equity fell by 100% in 1 year.
DChirnoaga
Lifetime
4 annual accounts with figures on one time axispeak €290,727 (2025)
€290,727▲ 10.5%
peak €210,098 (2025)
€210,098▲ 1.0%
peak €428,981 (2024)
€1,000▼ 99.8%
€500,857▲ 108%
Board1 name since 2022
1 director
Documentsfilings and deeds
29-05-202663 days before the deadline
2025micro format
Dividend €638,079Equity from €428,981 to €1,000Debts from €240,679 to €500,857
Key points
from the 2025 annual accountsTurnover
≈ €440,000 estimated
The micro format states no turnover.
Debts
€500,857 100% of the balance sheet
Financial debts 13%Taxes and wages 28%Other 60%
Of this, €438,193 falls due within a year.
Liquidity
0.95 was 3.55 in 2024
Short-term debts rose from €156,557 to €438,193.
Filings
4 annual accounts 2 late
The 2024 accounts came latest: 39 days after the end of the period.
Position in the sector
0.2%
Lower solvency than 95% of companies in human health. Sector median 63.1% · 21,322 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 513 companies had the same profile as DChirnoaga has now. Each dot stands for 2 companies, two years later.
96.3%
were still trading
1.4%
stopped another way
2.3%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 513 companies, not a prediction for DChirnoaga. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0781578884
First establishment
Warmoesstraat 157, Saint-Josse-ten-Noode
Incorporation
Founding capital of €1,000, 100 shares · Founder: · Appointment: (director) · published on 07-02-2022 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DChirnoaga Saint-Josse-ten-Noode | €501,857 | €290,727 | 0.2% | - |
| Dr. Bernd Lannau - Reconstructieve en esthetische chirurgie Ghent | €511,802 | €297,374 | 87.6% | - |
| OPHTALMOLOGUE NIZETTE GAËLLE Liège | €492,869 | €277,209 | 22.5% | - |
| ARDS Oupeye | €473,700 | €291,551 | 28.4% | - |
| Hanquet Olivier Ham-sur-Heure-Nalinnes | €474,319 | €297,547 | 1.1% | - |
| DR. THIJS LIESBETH Alken | €496,589 | €273,321 | 45.3% | - |
| Dr. Bastiaan Sol, Endocrinologie Ghent | €452,475 | €303,130 | 0.2% | - |
These companies have the same main activity as DChirnoaga: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €452,000 and €512,000, founded between 2021 and 2022.
Official details
Source: KBO- Status
- Active since 03-02-2022Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.336.707.3331210 Saint-Josse-ten-Noode, since 01-03-2022
- Financial year end
- 31 December
- Peppol
- Reachable since 12-12-2025
Annual accounts 2025
- €501,857▼ 25.1%
- Filing
- Filed on 29-05-2026, 63 days before the end of the filing period
Insights on DChirnoaga
DChirnoaga files the micro format. That format states no turnover. The gross margin rose from €160,238 in 2022 to €290,727 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DChirnoaga
- What is the company number of DChirnoaga?
- The company number of DChirnoaga is 0781.578.884. The VAT number is the same number with BE in front: BE 0781.578.884.
- Where is DChirnoaga based?
- The registered office is at Warmoesstraat 157, 1210 Saint-Josse-ten-Noode.Company details
- What does DChirnoaga do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of DChirnoaga?
- DChirnoaga is a private limited company (BV).
- When was DChirnoaga founded?
- DChirnoaga was founded on 03-02-2022.
- Is DChirnoaga still active?
- Yes, DChirnoaga is an active enterprise in the KBO register.
- What is the turnover of DChirnoaga?
- The turnover in financial year 2025 is ≈ €440,000. This figure is estimated from the gross margin of €290,727 and 31 comparable companies (NACE 86220). It probably lies between €390,000 and €610,000.Financials
- Is DChirnoaga profitable?
- In financial year 2025, DChirnoaga made a profit of €210,098.
- Where can I find the annual accounts of DChirnoaga?
- DChirnoaga filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DChirnoaga due?
- DChirnoaga must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.